The FDA approved carbachol/brimonidine tartrate ophthalmic solution (Yuvezzi) for adults with presbyopia, making it the first approved dual-agent eye drop therapy for age-related vision decline. The ...
A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment ...
Glaucoma impacts the vision of more than 3 million Americans, increasing the pressure in the eye, damaging the optic nerve and, if left untreated, causing permanent damage and vision loss. Until now, ...
For people with age-related blurry vision, once-a-day prescription eye drops offer a quick fix that lasts for up to 10 hours. Vizz (aceclidine ophthalmic solution) eye drops received FDA approval for ...
Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa. Researchers at ...
Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the United States. The Stats don’t lie: after age 65, most people will struggle ...
As people age, many develop presbyopia — age-related farsightedness that makes it hard to read things at close range — and may turn to reading glasses. But new research suggests another option may be ...
People with so-called "resting squint face" may seem like they are perpetually angry, but they may just be having trouble seeing. Focusing on close objects becomes increasingly difficult as people age ...
New research demonstrated that special eye drops allowed patients to read extra lines on an eyesight chart for up to two years. Reading time 3 minutes If you haven’t yet experienced it yourself, ...
Patients with presbyopia had consistent and durable vision improvement across multiple doses of a combination eye drop solution, a large retrospective review showed. From 69% to 99% of patients had ...
Eye drops combining pilocarpine and diclofenac helped patients read extra lines on vision charts, with effects lasting up to two years. The treatment could revolutionize presbyopia care as a safe, non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results